Rice Hall James & Associates LLC Has $3.10 Million Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Rice Hall James & Associates LLC lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 33.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,949 shares of the company's stock after acquiring an additional 8,831 shares during the period. Rice Hall James & Associates LLC owned about 0.23% of U.S. Physical Therapy worth $3,100,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Creative Planning acquired a new stake in U.S. Physical Therapy in the third quarter worth $252,000. Precision Wealth Strategies LLC increased its position in U.S. Physical Therapy by 5.1% in the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company's stock worth $239,000 after buying an additional 137 shares during the period. International Assets Investment Management LLC increased its position in U.S. Physical Therapy by 8,414.8% in the third quarter. International Assets Investment Management LLC now owns 2,299 shares of the company's stock worth $195,000 after buying an additional 2,272 shares during the period. Semanteon Capital Management LP acquired a new stake in U.S. Physical Therapy in the third quarter worth $776,000. Finally, Cambiar Investors LLC increased its position in U.S. Physical Therapy by 31.3% in the third quarter. Cambiar Investors LLC now owns 26,655 shares of the company's stock worth $2,256,000 after buying an additional 6,350 shares during the period.

U.S. Physical Therapy Price Performance

USPH stock traded down $2.16 during trading hours on Friday, hitting $83.91. 141,272 shares of the stock traded hands, compared to its average volume of 86,652. The stock has a 50-day simple moving average of $89.21 and a 200 day simple moving average of $87.82. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The company has a market cap of $1.27 billion, a P/E ratio of 89.26, a P/E/G ratio of 3.62 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

Insider Activity at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the firm's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares of the company's stock, valued at $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.70% of the company's stock.

Analyst Ratings Changes

USPH has been the topic of several analyst reports. Barrington Research reaffirmed an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. JPMorgan Chase & Co. increased their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 3rd. JMP Securities initiated coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 price target for the company. Finally, Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price target for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $114.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.